Real-time Stock quotes, portfolio, LIVE TV and more.
|
Jul 09, 2009, 05.45 PM IST
IIFL has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, GlaxoSmithkline Pharma's June quarter sales is expected to go up by 36% to Rs 454.4 crore on YoY basis.
IIFL has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, GlaxoSmithkline Pharma 's June quarter sales is expected to go up by 36% to Rs 454.4 crore on YoY basis.
The company's PAT (profit after tax) is expected to go up 11.5% to Rs 128 crore on YoY basis.
Related News Set email alert for Tags: IIFL, GlaxoSmithkline Pharma
|
News Videos
|